Skip to main content
. 2012 Sep 10;20(1):32. doi: 10.1186/2008-2231-20-32

Table 7.

Average cost saving for 1.7% HbA1c reduction

Complications Average cost per patient (USD) Average reduction for 1.7% HbA1c improvement (%) Average Cost saving (USD)
Microvascular
61.98
62.9
38.98
Cardiovascular disease
106.20
23.8
25.28
Peripheral vascular disease
20.53
73.1
15.00
Ophthalmic
35.00
32.3
11.31
Disability and mortality
216.20
29.75
64.32
Total 439.9   154.89

USD; USA Dollars.